More Details on This News

Jeena Sikho Lifecare Limited has announced the publication of three academic papers: two case studies and one case report, in the International Journal of Ayurveda and Herbal Research and the Journal of Applied Science and Education. These publications, co-authored by the company's Managing Director, Acharya Manish Grover, along with other medical professionals from the company, highlight the advancement of Ayurvedic research and the promotion of evidence-based clinical practices.

The case studies focus on the management of Chronic Kidney Disease (CKD) using Ayurvedic therapies. One study details a case of a 56-year-old male patient with Stage V CKD, hypertension, Type 2 Diabetes Mellitus, and Coronary Artery Disease. The integrated treatment, combining Ayurvedic medications with a disciplined intelligent person's (DIP) diet and lifestyle modifications, showed significant improvements. Key results included a reduction in blood urea from 230.86 mg/dL to 117.39 mg/dL, serum creatinine from 6.32 mg/dL to 5.17 mg/dL, and uric acid from 7.80 mg/dL to 6.36 mg/dL. Pedal edema decreased from grade 3 to grade 1, and severe weakness was alleviated.

The publications aim to reflect the company's commitment to evidence-based Ayurvedic practices and suggest the potential of Ayurveda as a complementary approach to managing complex conditions like CKD. The company emphasizes that while findings are promising, further larger randomized controlled trials are necessary to establish standardized treatment guidelines.